Detection of Epstein-Barr Virus (EBV) by Real-Time PCR and Evaluation of Immunological Markers (IL-6, IFN-γ) and Biochemical Liver Enzymes in Patients with Nasopharyngeal Carcinoma
Journal of Health and Biology · 17.06.2026 · 2 (1) · 108-116
DOI: 10.71428/jhb.2026.0112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health and Biology, online erschienen am 17.06.2026. Verfasst von Ali Jameel.
Abstract (Originalsprache)
Background & Aim: Nasopharyngeal carcinoma (NPC) is an epithelial malignancy connected to Epstein-Barr virus (EBV) infection in endemic areas. Through real-time quantitative PCR (qPCR), this study detected EBV-DNA in NPC patients and assessed immunological markers (IL-6, IFN-γ), ALT, AST, and ALP.
Methods
80 newly diagnosed NPC patients and 40 healthy controls were evaluated in a case-control study. Plasma EBV-DNA was quantified by TaqMan real-time PCR using the BamHI-W repeat region. Liver enzymes were measured using kinetic spectrophotometry, while serum IL-6 and IFN-γ were measured using sandwich ELISA.
Results
EBV-DNA was detected in 88.7% of NPC patients (71/80), with a mean viral burden of 4.82 ± 1.13 log₁₀ copies/mL. Negative controls. Patients had considerably greater IL-6 and IFN-γ levels than controls (p < 0.001), with IL-6 positively correlated with EBV virus load (r = 0.612). Some people showed mildly elevated ALT and AST, indicating secondary hepatic involvement.
Conclusion
These data support plasma EBV-DNA quantification in NPC diagnosis and suggest a link between viral replication and immunological dysfunction. The biomarker panel (EBV-DNA + IL-6 + IFN-γ) may aid in disease monitoring and patient stratification in EBV-associated NPC.
Zitieren
APA
Jameel, A. (2026). Detection of Epstein-Barr Virus (EBV) by Real-Time PCR and Evaluation of Immunological Markers (IL-6, IFN-γ) and Biochemical Liver Enzymes in Patients with Nasopharyngeal Carcinoma. Journal of Health and Biology, 2(1), 108-116. https://doi.org/10.71428/jhb.2026.0112
Vancouver
Jameel A. Detection of Epstein-Barr Virus (EBV) by Real-Time PCR and Evaluation of Immunological Markers (IL-6, IFN-γ) and Biochemical Liver Enzymes in Patients with Nasopharyngeal Carcinoma. Journal of Health and Biology. 2026;2(1):108-116. doi:10.71428/jhb.2026.0112
BibTeX
@article{Jameel2026,
author = {Jameel, Ali},
title = {Detection of Epstein-Barr Virus (EBV) by Real-Time PCR and Evaluation of Immunological Markers (IL-6, IFN-γ) and Biochemical Liver Enzymes in Patients with Nasopharyngeal Carcinoma},
journal = {Journal of Health and Biology},
year = {2026},
volume = {2},
number = {1},
pages = {108--116},
doi = {10.71428/jhb.2026.0112}
}
EUVIMED